Sunday, 22 April 2018

IPAQT to offer HIV, HCV diagnostic tests at half-price

09 March 2018 | News

IPAQT has been successful in negotiating with Cepheid, manufacturer of the GeneXpert platform, to significantly reduce the price for these critical diagnostic tests.

Image credit- pinterest.com

Image credit- pinterest.com

A consortium of private sector diagnostic laboratories, Initiative for Promoting Affordable and Quality Tests (IPAQT) is planning to offer the World Health Organisation (WHO)-endorsed GeneXpert HCV and HIV viral load tests at less than 50 per cent of the market price in India.

Currently, the consortium has almost 200 members who offer WHO-endorsed TB tests, such as GeneXpert, Hain LPA, BacTALERT 3D, and MGIT. IPAQT laboratories have increased the adoption of quality TB tests from 28,000 in 2013 to over 2,40,000 tests in 2017.

IPAQT has been successful in negotiating with Cepheid, manufacturer of the GeneXpert platform, to significantly reduce the price for these critical diagnostic tests. IPAQT laboratories and hospitals can now offer the GeneXpert HCV and HIV viral load tests at no more than Rs 2,600 (US$40) and Rs 2,800 (US$43) respectively, while the market rate for these tests vary between Rs 4500 (US$69) and Rs 7,000 (US$108).

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Can access to vaccines reduce the threat of antibiotic resistance?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls